Coinfection of HIV/tuberculosis in Primorsky Territory
E. V. Eliseeva, 
V. A. Eremeeva,
L. F. Sklyar,
L. I. Shishkova,
S. N. Beniova,
O. N. Li,
V. S. Kopaev,
Е. V. Ryazanova
V. A. Eremeeva,
L. F. Sklyar,
L. I. Shishkova,
S. N. Beniova,
O. N. Li,
V. S. Kopaev,
Е. V. Ryazanova https://doi.org/10.34215/1609-1175-2021-1-51-55
Abstract
Objective: To highlight the features of the epidemiological tuberculosis among HIV patients in Primorsky region.
Methods: Statistical data of the epidemiological monitoring, forms of federal monitoring and industry reporting, medical records of the Primorsky Regional Anti-Tuberculosis Dispensary and HIV and infectious diseases prevention center were analyzed.
Results: As a rule HIV-associated tuberculosis was identified during the fourth stage of HIV-infection on the basis of accompanying diseases and most of all in infiltrative form. As a rule at the moment of diagnosing HIV-infection low indexes of CD4+-lymphocytes level were registered. It was indicative to severe immunodeficiency. Tuberculosis chemoprevention according to indications among children having HIV was conducted not in all cases. It is connected with multiple refuses and stopping treatment.
Conclusions: Primorsky region is considered to have an unfavorable epidemiological situation in Russia not only according to HIV rate but also to tuberculosis rate. The relevance of the problem of comorbidity of these diseases has increased in recent years.
About the Authors
E. V. Eliseeva
Pacific State Medical University
Russian Federation
Russian Federation
Ekaterina V. Eliseeva, MD, PhD, professor, head of the Department of General and Clinical Pharma-cology.
2 Ostryakova Ave., Vladivostok, 690002
V. A. Eremeeva
Pacific State Medical University
Russian Federation
Russian Federation
Viktoria A. Eremeeva, MD, General and Clinical Pharmacology Department.
2 Ostryakova Ave., Vladivostok, 690002
L. F. Sklyar
Pacific State Medical University; Regional Clinical Hospital No. 2; Far Eastern Federal University
Russian Federation
Russian Federation
Lidia F. Sklyar, MD, PhD, professor, Department of Infectious Diseases, Pacific SMU; Far Eastern Federal University, deputy chief physician, RCH No. 2.
10 Ajax, Russky Island, Vladivostok, 690922; 55 Russkaya St., Vladivostok, 690105
L. I. Shishkova
Primorsky Regional Anti-Tuberculosis Dispensary
Russian Federation
Russian Federation
Lyudmila I. Shishkova, MD, deputy chief physician for clinical expert work.
2 Pyatnadtsataya St., Vladivostok, 690041
S. N. Beniova
Regional Clinical Hospital No. 2; Far Eastern Federal University
Russian Federation
Russian Federation
Svetlana N. Beniova, MD, PhD, chief physician.
55 Russkaya St., Vladivostok, 690105
O. N. Li
Pacific State Medical University
Russian Federation
Russian Federation
Olga N. Li, MD, PhD, professor, General and Clinical Pharmacology Department.
2 Ostryakova Ave., Vladivostok, 690002
V. S. Kopaev
Pacific State Medical University
Russian Federation
Russian Federation
Vladislav S. Kopaev, student.
2 Ostryakova Ave., Vladivostok, 690002
Е. V. Ryazanova
Pacific State Medical University
Russian Federation
Russian Federation
Elena V. Ryazanova, MD, graduate student.
2 Ostryakova Ave., Vladivostok, 690002
References
1. Azovtseva OV, Gritsyuk AV, Gemaeva MD, Karpov AV. HIV infection and tuberculosis as the most difficult variant of comorbidity. Bulletin of Novgorod State University Yaroslav the Wise. 2020;1:79-84 (In Russ).
2. Zagdyn ZM. Organizational and clinical and epidemiological approaches to antiretroviral therapy and chemoprophylaxis of tuberculosis and the incidence of tuberculosis among people living with HIV. Health Manager. 2019;5:23-9 (In Russ).
3. Liskina I.V., Kuzovkova S.D., Zagaba L.M., Nikolaeva O.D. Tuberculosis/HIV co-infection in hospitalized patients with phthisiopulmonary profile: Frequency, forms of lesion, peculiarities of diagnosis (according to the data of a highly specialized institution). Tuberculosis, Pulmonary Diseases, HIV Infection. 2019;3:5-13 (In Ukr).
4. Motanova LN, Grabovskaya MS, Sklyar LF, Polyakova NA, Folts IV. Epidemic situation on tuberculosis in patients with HIV infection in the Primorsky Territory. Tuberculosis and HIV Infection. 2019;3:23-9 (In Russ).
5. Decree of the Government of the Russian Federation of 01.12.2004 No. 715 (as amended on 31.01.2020) “On approval of the list of socially significant diseases and the list of diseases that pose a danger to others” (In Russ). URL: https://legalacts.ru/doc/postanovlenie-pravitelstva-rf-ot-01122004-n-715 (Accessed 14 December 2020).
6. Клинические стадии ВИЧ-инфекции, установленные по классификации В.И. Покровского (2006). [Clinical stages of HIV infection established by VI Pokrovsky, 2006 (In Russ).] URL: http://www.ufaaids.bashmed.ru/personal/vse-o-vich-spide.php (Accessed 18 December 2020).
7. Frolova OP, Zhilenkov SG, Butylchenko OV, Martel II. A case of tuberculosis during the period oftransient immunodeficiency associated with HIV infection. Tuberculosis and Lung Disease. 2020;98(3):52-6 (In Russ).
8. Lepshina SM, Lyakhimets VA, Kukurika AV, Serdyuk OV The spectrum of MBT drug resistance to anti-tuberculosis drugs in patients with newly diagnosed and «repeated» cases of HIV/TB-resistant co-infection. Bulletin of Hygiene and Epidemiology. 2020;24(2):189-92 (In Russ).
9. Asmanova MA, Lukyanenko NV, Yurova VA, Solodilova OA. Comparative aspects of the effectiveness of microbiological methods for determining the massiveness of bacterial excretion in patients with tuberculosis and concomitant pathology (HIV infection and tuberculosis). Modern Science: Actual Problems of Theory and Practice. 2020;4:163-6 (In Russ).
10. Zhao I, Zagdyn ZM, Pavlova MV, Archakova LI. Tuberculosis and HIV infection in the Russian Federation: Risk factors for MDR-TB among patients with HIV infection (review). Medical Alliance. 2020;8(1):6-13 (In Russ).
11. Decree of the President of the Russian Federation of06.06.2019 No. 254 “On the strategy for the development of healthcare in the Russian Federation for the period up to 2025” (In Russ). URL: http://base.garant.ru/72264534 (Accessed 21 December 2020).
12. Shivacoti R, Sharma D, Mamoon G, Pham K. Association of HIV infection with extrapulmonary tuberculosis: A systematic review. Infection. 2017;45:11-21.
13. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017 Update. URL: http://www.who.int/tb/publica-tions/2017/dstb_guidance_2017/en (Accessed 10 January 2021).
Review
For citations:
Eliseeva E.V., Eremeeva V.A., Sklyar L.F., Shishkova L.I., Beniova S.N., Li O.N., Kopaev V.S., Ryazanova Е.V. Coinfection of HIV/tuberculosis in Primorsky Territory. Pacific Medical Journal. 2021;(1):51-55. (In Russ.) https://doi.org/10.34215/1609-1175-2021-1-51-55
Views:
366
Email this article 